Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Determination of Absorptivity Values – V 2.0

Posted on By

Analytical Method Development: Determination of Absorptivity Values – V 2.0

SOP for Determination of Absorptivity Values in UV Spectrophotometric Method Development


Department Analytical Method Development
SOP No. SOP/AMD/092/2025
Supersedes SOP/AMD/092/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines the procedure for determining the absorptivity (specific absorbance) of Active Pharmaceutical Ingredients (APIs) using UV-visible spectrophotometry. Absorptivity values are critical for API identification, concentration

estimation, and compliance with pharmacopoeial standards.

2. Scope

This SOP applies to the Analytical Method Development (AMD) department and covers the determination of A1%1cm values of APIs and related substances in compliance with pharmacopeial monographs and ICH guidelines.

3. Responsibilities

  • Analytical Chemist: Prepares test solutions, performs spectrophotometric analysis, and calculates absorptivity values.
  • Method Reviewer: Reviews and verifies calculated data and confirms system suitability.
  • QA Officer: Ensures GMP-compliant documentation and adherence to procedural controls.
  • Head – AMD: Approves the absorptivity data and method outcome.
See also  Analytical Method Development: Dissolution Media Selection SOP - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring accuracy, traceability, and regulatory compliance of absorptivity determination processes within the AMD department.

5. Procedure

5.1 Principle

  1. Absorptivity (A1%1cm) is defined as the absorbance of a 1% w/v solution measured in a 1 cm path length cuvette at a specified wavelength.
  2. It is calculated using:
    A1%1cm = (A × 100) / C
    

    where A = measured absorbance, C = concentration in mg/mL

5.2 Wavelength Selection

  1. Scan the UV spectrum of the test API (200–400 nm) using appropriate solvent.
  2. Select λmax (wavelength of maximum absorbance) with good molar absorptivity and no interference.
  3. Document spectrum and chosen λmax in Annexure-1: UV Scan Report.

5.3 Preparation of Standard Solution

  1. Weigh 10 mg of API (accurately) and transfer to a 100 mL volumetric flask.
  2. Dissolve using suitable solvent (water, methanol, ethanol, etc.), and dilute to volume.
  3. This gives 0.1 mg/mL = 0.01% w/v solution.
  4. Prepare additional concentrations as required.
  5. Record preparation in Annexure-2: Standard Preparation Log.

5.4 Measurement of Absorbance

  1. Blank the instrument with the same solvent used for dilution.
  2. Measure absorbance of prepared standard solutions at λmax using 1 cm quartz cuvettes.
  3. Run absorbance measurements in triplicate for accuracy.
  4. Log absorbance readings in Annexure-3: Absorbance Record Sheet.

5.5 Calculation of Absorptivity

  1. Use the formula:
    A1%1cm = (A × 100) / C
    

    where A = average absorbance and C = concentration in mg/mL.

  2. Example: A = 0.450, C = 1 mg/mL
    A1%1cm = (0.450 × 100) / 1 = 45.0
    
  3. Compare with pharmacopeial value (if available) for compliance.
  4. Record results in Annexure-4: Absorptivity Calculation Sheet.

5.6 System Suitability

  1. Check absorbance repeatability (%RSD ≤ 1.0% for triplicates).
  2. Verify blank shows negligible absorbance (< 0.005).
  3. Ensure consistent path length (1.00 ± 0.01 cm).
  4. Log suitability results in Annexure-5: System Suitability Log.

5.7 Documentation and Archival

  1. Ensure that all raw data, scan files, calculations, and analyst/reviewer initials are captured in the worksheet.
  2. Store printed spectra and logbooks for 5 years as per data retention policy.

6. Abbreviations

  • UV: Ultraviolet
  • API: Active Pharmaceutical Ingredient
  • A1%1cm: Absorptivity (1% w/v, 1 cm pathlength)
  • RSD: Relative Standard Deviation
  • SOP: Standard Operating Procedure

7. Documents

  1. UV Scan Report – Annexure-1
  2. Standard Preparation Log – Annexure-2
  3. Absorbance Record Sheet – Annexure-3
  4. Absorptivity Calculation Sheet – Annexure-4
  5. System Suitability Log – Annexure-5

8. References

  • USP <857> – Ultraviolet-Visible Spectroscopy
  • ICH Q2(R1) – Validation of Analytical Procedures
  • Indian Pharmacopoeia / British Pharmacopoeia / USP Monographs
  • Instrument Manual – UV-Vis Spectrophotometer

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: UV Scan Report

Sample ID Solvent Scan Range λmax (nm)
API-092 Methanol 200–400 nm 265

Annexure-2: Standard Preparation Log

Sample ID Weight (mg) Solvent Final Volume (mL)
STD-092 10.00 Methanol 100

Annexure-3: Absorbance Record Sheet

Replicate Absorbance
1 0.451
2 0.448
3 0.450

Annexure-4: Absorptivity Calculation Sheet

Average Absorbance Concentration (mg/mL) A1%1cm
0.450 1.0 45.0

Annexure-5: System Suitability Log

Parameter Observed Limit Status
%RSD (Absorbance) 0.33% ≤1.0% Pass
Blank Absorbance 0.003 <0.005 Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Updated calculation method and added replicates requirement Annual SOP Review
See also  Analytical Method Development: SOP for Accuracy Study Using Recovery Method - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Preventive Maintenance of Gel Manufacturing Equipment – V 2.0
Next Post: API Manufacturing: SOP for Trending of Analytical Results – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version